AER001
- Generic Name
- AER001
- Drug Type
- Small Molecule
Overview
AER001, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.
Background
AER001, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.
Indication
Investigated for use/treatment in asthma.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath